Skip to content
← Full study record

NCT00299104 · FLOW

Participant flow

A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid Arthritis · Source last updated 2017-07-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Placebo intravenously on Days 1 and 15 + a background of methotrexate orally at a dose of 7.5 mg escalating by 2.5 mg a week every 1-2 weeks to achieve: 15 mg per week by Week 4 and 20 mg per week by Week 8. From Week 104 participants were eligible to receive Rituximab 2 X 0.5 g or Rituximab 2 X 1.0 g every 24 weeks.
    id
    FG000
    title
    Placebo + Methotrexate
  2. description
    Rituximab intravenously at a dose of 0.5 g on Days 1 and 15 + a background of methotrexate orally at a dose of 7.5 mg escalating by 2.5 mg a week every 1-2 weeks to achieve: 15 mg per week by Week 4 and 20 mg per week by Week 8. Subsequent Rituximab treatment courses were given at 24 week intervals for 5 years provided the Disease Activity Score 28 Joint Count- Erythrocyte Sedimentation Rate (DAS-ESR) result was ≥2.6
    id
    FG001
    title
    Rituximab (0.5 g x 2) + Methotrexate
  3. description
    Rituximab intravenously at a dose of 1.0 g on Days 1 and 15 + a background of methotrexate orally at a dose of 7.5 mg escalating by 2.5 mg a week every 1-2 weeks to achieve: 15 mg per week by Week 4 and 20 mg per week by Week 8. Subsequent Rituximab treatment courses were given at 24 week intervals for 5 years provided the Disease Activity Score 28 Joint Count- Erythrocyte Sedimentation Rate (DAS-ESR) result was ≥2.6
    id
    FG002
    title
    Rituximab (1.0 g x 2) + Methotrexate
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        14
      2. group Id
        FG001
        num Subjects
        9
      3. group Id
        FG002
        num Subjects
        7
      type
      Adverse Event
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        1
      type
      Death
    3. reasons
      1. group Id
        FG000
        num Subjects
        34
      2. group Id
        FG001
        num Subjects
        13
      3. group Id
        FG002
        num Subjects
        8
      type
      Insufficient therapeutic response
    4. reasons
      1. group Id
        FG000
        num Subjects
        9
      2. group Id
        FG001
        num Subjects
        8
      3. group Id
        FG002
        num Subjects
        8
      type
      Failure to return
    5. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        2
      3. group Id
        FG002
        num Subjects
        0
      type
      Violation of selection criteria
    6. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        0
      type
      Protocol Violation
    7. reasons
      1. group Id
        FG000
        num Subjects
        9
      2. group Id
        FG001
        num Subjects
        2
      3. group Id
        FG002
        num Subjects
        2
      type
      Refused treatment
    8. reasons
      1. group Id
        FG000
        num Subjects
        14
      2. group Id
        FG001
        num Subjects
        19
      3. group Id
        FG002
        num Subjects
        9
      type
      Withdrew consent
    9. reasons
      1. group Id
        FG000
        num Subjects
        106
      2. group Id
        FG001
        num Subjects
        120
      3. group Id
        FG002
        num Subjects
        137
      type
      Administrative reasons
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        251
      2. group Id
        FG001
        num Subjects
        252
      3. group Id
        FG002
        num Subjects
        252
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        249
      2. group Id
        FG001
        num Subjects
        249
      3. group Id
        FG002
        num Subjects
        250
      type
      Safety/ITT: Received Study Drug
    3. achievements
      1. group Id
        FG000
        num Subjects
        227
      2. group Id
        FG001
        num Subjects
        240
      3. group Id
        FG002
        num Subjects
        241
      type
      Completed Week 24
    4. achievements
      1. group Id
        FG000
        num Subjects
        213
      2. group Id
        FG001
        num Subjects
        227
      3. group Id
        FG002
        num Subjects
        232
      type
      Completed Week 52
    5. achievements
      1. group Id
        FG000
        num Subjects
        178
      2. group Id
        FG001
        num Subjects
        213
      3. group Id
        FG002
        num Subjects
        216
      type
      Completed Week 104
    6. achievements
      1. comment
        Completed Week 152
        group Id
        FG000
        num Subjects
        62
      2. group Id
        FG001
        num Subjects
        77
      3. group Id
        FG002
        num Subjects
        80
      type
      COMPLETED
    7. achievements
      1. group Id
        FG000
        num Subjects
        189
      2. group Id
        FG001
        num Subjects
        175
      3. group Id
        FG002
        num Subjects
        172
      type
      NOT COMPLETED
    title
    Treatment Period
  2. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        3
      2. group Id
        FG001
        num Subjects
        2
      3. group Id
        FG002
        num Subjects
        1
      type
      Death
    2. reasons
      1. group Id
        FG000
        num Subjects
        9
      2. group Id
        FG001
        num Subjects
        11
      3. group Id
        FG002
        num Subjects
        20
      type
      Lost to Follow-up
    3. reasons
      1. group Id
        FG000
        num Subjects
        16
      2. group Id
        FG001
        num Subjects
        21
      3. group Id
        FG002
        num Subjects
        11
      type
      Withdrawal by Subject
    4. reasons
      1. group Id
        FG000
        num Subjects
        27
      2. group Id
        FG001
        num Subjects
        7
      3. group Id
        FG002
        num Subjects
        5
      type
      Administrative reasons
    milestones
    1. achievements
      1. comment
        All participants who received treatment were to enter SFU even if withdrawn during treatment period.
        group Id
        FG000
        num Subjects
        184
      2. comment
        All participants who received treatment were to enter SFU even if withdrawn during treatment period.
        group Id
        FG001
        num Subjects
        212
      3. comment
        All participants who received treatment were to enter SFU even if withdrawn during treatment period.
        group Id
        FG002
        num Subjects
        213
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        129
      2. group Id
        FG001
        num Subjects
        171
      3. group Id
        FG002
        num Subjects
        176
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        55
      2. group Id
        FG001
        num Subjects
        41
      3. group Id
        FG002
        num Subjects
        37
      type
      NOT COMPLETED
    title
    Safety Follow-Up (SFU) Period
  3. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        0
      type
      Death
    2. reasons
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        2
      3. group Id
        FG002
        num Subjects
        2
      type
      Lost to Follow-up
    3. reasons
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        4
      3. group Id
        FG002
        num Subjects
        8
      type
      Withdrawal by Subject
    4. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        2
      3. group Id
        FG002
        num Subjects
        2
      type
      Administrative reasons
    milestones
    1. achievements
      1. comment
        Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.
        group Id
        FG000
        num Subjects
        34
      2. comment
        Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.
        group Id
        FG001
        num Subjects
        40
      3. comment
        Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.
        group Id
        FG002
        num Subjects
        51
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        29
      2. group Id
        FG001
        num Subjects
        31
      3. group Id
        FG002
        num Subjects
        39
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        5
      2. group Id
        FG001
        num Subjects
        9
      3. group Id
        FG002
        num Subjects
        12
      type
      NOT COMPLETED
    title
    Extended Safety Follow-Up (ESFU) Period
Complete source fields
groups
  1. description
    Placebo intravenously on Days 1 and 15 + a background of methotrexate orally at a dose of 7.5 mg escalating by 2.5 mg a week every 1-2 weeks to achieve: 15 mg per week by Week 4 and 20 mg per week by Week 8. From Week 104 participants were eligible to receive Rituximab 2 X 0.5 g or Rituximab 2 X 1.0 g every 24 weeks.
    id
    FG000
    title
    Placebo + Methotrexate
  2. description
    Rituximab intravenously at a dose of 0.5 g on Days 1 and 15 + a background of methotrexate orally at a dose of 7.5 mg escalating by 2.5 mg a week every 1-2 weeks to achieve: 15 mg per week by Week 4 and 20 mg per week by Week 8. Subsequent Rituximab treatment courses were given at 24 week intervals for 5 years provided the Disease Activity Score 28 Joint Count- Erythrocyte Sedimentation Rate (DAS-ESR) result was ≥2.6
    id
    FG001
    title
    Rituximab (0.5 g x 2) + Methotrexate
  3. description
    Rituximab intravenously at a dose of 1.0 g on Days 1 and 15 + a background of methotrexate orally at a dose of 7.5 mg escalating by 2.5 mg a week every 1-2 weeks to achieve: 15 mg per week by Week 4 and 20 mg per week by Week 8. Subsequent Rituximab treatment courses were given at 24 week intervals for 5 years provided the Disease Activity Score 28 Joint Count- Erythrocyte Sedimentation Rate (DAS-ESR) result was ≥2.6
    id
    FG002
    title
    Rituximab (1.0 g x 2) + Methotrexate
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        14
      2. group Id
        FG001
        num Subjects
        9
      3. group Id
        FG002
        num Subjects
        7
      type
      Adverse Event
    2. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        1
      type
      Death
    3. reasons
      1. group Id
        FG000
        num Subjects
        34
      2. group Id
        FG001
        num Subjects
        13
      3. group Id
        FG002
        num Subjects
        8
      type
      Insufficient therapeutic response
    4. reasons
      1. group Id
        FG000
        num Subjects
        9
      2. group Id
        FG001
        num Subjects
        8
      3. group Id
        FG002
        num Subjects
        8
      type
      Failure to return
    5. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        2
      3. group Id
        FG002
        num Subjects
        0
      type
      Violation of selection criteria
    6. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        0
      type
      Protocol Violation
    7. reasons
      1. group Id
        FG000
        num Subjects
        9
      2. group Id
        FG001
        num Subjects
        2
      3. group Id
        FG002
        num Subjects
        2
      type
      Refused treatment
    8. reasons
      1. group Id
        FG000
        num Subjects
        14
      2. group Id
        FG001
        num Subjects
        19
      3. group Id
        FG002
        num Subjects
        9
      type
      Withdrew consent
    9. reasons
      1. group Id
        FG000
        num Subjects
        106
      2. group Id
        FG001
        num Subjects
        120
      3. group Id
        FG002
        num Subjects
        137
      type
      Administrative reasons
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        251
      2. group Id
        FG001
        num Subjects
        252
      3. group Id
        FG002
        num Subjects
        252
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        249
      2. group Id
        FG001
        num Subjects
        249
      3. group Id
        FG002
        num Subjects
        250
      type
      Safety/ITT: Received Study Drug
    3. achievements
      1. group Id
        FG000
        num Subjects
        227
      2. group Id
        FG001
        num Subjects
        240
      3. group Id
        FG002
        num Subjects
        241
      type
      Completed Week 24
    4. achievements
      1. group Id
        FG000
        num Subjects
        213
      2. group Id
        FG001
        num Subjects
        227
      3. group Id
        FG002
        num Subjects
        232
      type
      Completed Week 52
    5. achievements
      1. group Id
        FG000
        num Subjects
        178
      2. group Id
        FG001
        num Subjects
        213
      3. group Id
        FG002
        num Subjects
        216
      type
      Completed Week 104
    6. achievements
      1. comment
        Completed Week 152
        group Id
        FG000
        num Subjects
        62
      2. group Id
        FG001
        num Subjects
        77
      3. group Id
        FG002
        num Subjects
        80
      type
      COMPLETED
    7. achievements
      1. group Id
        FG000
        num Subjects
        189
      2. group Id
        FG001
        num Subjects
        175
      3. group Id
        FG002
        num Subjects
        172
      type
      NOT COMPLETED
    title
    Treatment Period
  2. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        3
      2. group Id
        FG001
        num Subjects
        2
      3. group Id
        FG002
        num Subjects
        1
      type
      Death
    2. reasons
      1. group Id
        FG000
        num Subjects
        9
      2. group Id
        FG001
        num Subjects
        11
      3. group Id
        FG002
        num Subjects
        20
      type
      Lost to Follow-up
    3. reasons
      1. group Id
        FG000
        num Subjects
        16
      2. group Id
        FG001
        num Subjects
        21
      3. group Id
        FG002
        num Subjects
        11
      type
      Withdrawal by Subject
    4. reasons
      1. group Id
        FG000
        num Subjects
        27
      2. group Id
        FG001
        num Subjects
        7
      3. group Id
        FG002
        num Subjects
        5
      type
      Administrative reasons
    milestones
    1. achievements
      1. comment
        All participants who received treatment were to enter SFU even if withdrawn during treatment period.
        group Id
        FG000
        num Subjects
        184
      2. comment
        All participants who received treatment were to enter SFU even if withdrawn during treatment period.
        group Id
        FG001
        num Subjects
        212
      3. comment
        All participants who received treatment were to enter SFU even if withdrawn during treatment period.
        group Id
        FG002
        num Subjects
        213
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        129
      2. group Id
        FG001
        num Subjects
        171
      3. group Id
        FG002
        num Subjects
        176
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        55
      2. group Id
        FG001
        num Subjects
        41
      3. group Id
        FG002
        num Subjects
        37
      type
      NOT COMPLETED
    title
    Safety Follow-Up (SFU) Period
  3. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        0
      2. group Id
        FG001
        num Subjects
        1
      3. group Id
        FG002
        num Subjects
        0
      type
      Death
    2. reasons
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        2
      3. group Id
        FG002
        num Subjects
        2
      type
      Lost to Follow-up
    3. reasons
      1. group Id
        FG000
        num Subjects
        2
      2. group Id
        FG001
        num Subjects
        4
      3. group Id
        FG002
        num Subjects
        8
      type
      Withdrawal by Subject
    4. reasons
      1. group Id
        FG000
        num Subjects
        1
      2. group Id
        FG001
        num Subjects
        2
      3. group Id
        FG002
        num Subjects
        2
      type
      Administrative reasons
    milestones
    1. achievements
      1. comment
        Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.
        group Id
        FG000
        num Subjects
        34
      2. comment
        Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.
        group Id
        FG001
        num Subjects
        40
      3. comment
        Only participants with CD19+ B-cell counts below baseline level or less than 80 cells/microliter.
        group Id
        FG002
        num Subjects
        51
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        29
      2. group Id
        FG001
        num Subjects
        31
      3. group Id
        FG002
        num Subjects
        39
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        5
      2. group Id
        FG001
        num Subjects
        9
      3. group Id
        FG002
        num Subjects
        12
      type
      NOT COMPLETED
    title
    Extended Safety Follow-Up (ESFU) Period

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice